#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rhabdomyosarcoma Peripheral T-cell lymphoma unspecified Adult T-cell lymphoma/leukaemia refractory Pleomorphic leiomyosarcoma Biotinidase deficiency Neutropenia Primitive neuroectodermal tumour Rectal cancer Metastases to central nervous system Multifocal motor neuropathy Pustular psoriasis Noonan syndrome Non-renal cell carcinoma of kidney Spinal cord injury cervical Mitochondrial myopathy More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma – Diagnostics Rhabdomyosarcoma – Basic Information Familial amyotrophic lateral sclerosis – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Netherton’s syndrome – Trials in Disease Glycogen storage disease type II – Trials in Disease Chordoma – Life with Disease Thrombotic thrombocytopenic purpura – Basic Information Arterial tortuosity syndrome – Diagnostics Angiosarcoma recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Purified Egg Phospholipids Obeticholic Acid Emedastine [14C]ZIPALERTINIB [18F] CANAGLIFLOZIN Naltrexone Hydrochloride NALOXEGOL Methylprednisolone MEGESTROL ACETATE Lurasidone Ro7269162 Incb099280 Sirolimus Volrustomig Clic-1901 Cart Ttf-Ngr Carcik-Cd19 Cells Anselamimab Asfotase Alfa Dapagliflozin More therapies…

    Learn about Your Condition

    Hydrocele Dyspepsia Dengue fever Frontotemporal dementia Non-Hodgkin's lymphoma Carcinoid syndrome Escherichia infection Fibrous dysplasia of bone Irritable bowel syndrome Macular oedema Meningococcal infection Glomerulonephritis chronic Seasonal allergy Cancer pain Acute respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Elixirium Thymi Compositum for Treating Acute Bronchitis in Children

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bronchitis
    Investigated Drugs:
    • LIQUID EXTRACT OF THYME (1:3.45-3.85), EXTRACTION SOLVENT: ETHANOL 27%(V/V)
    Hungary

  • Study of M9140 for Patients With Advanced Pancreatic Cancer

    Not yet recruiting

    1 1 1
    Austria France Germany Italy Spain

  • Study on Amlodipine for Treating Reversible Cerebral Vasoconstriction Syndrome in Patients Without Brain Lesions or Hemorrhage

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Amlodipine
    Finland

  • Study on the Safety and Effects of Rapcabtagene Autoleucel, Tocilizumab, Fludarabine Phosphate, and Cyclophosphamide for Patients with Rheumatoid Arthritis and Sjogren’s Disease

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    France Germany Hungary Italy Spain

  • Study on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Tezepelumab
    • Placebo
    Italy

  • Study of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    France
Previous Page
1 … 796 797 798 799 800 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!